MPO Staff02.22.22
Corza Medical has conducted its first add-on acquisition since its formation last winter.
The company purchased Katena Products Inc. but did not disclose deal terms. "The addition of Katena is highly complementary to our existing surgical product portfolio," Corza Executive Chairman Greg Lucier said. "This acquisition underscores our dedication to serving customers with differentiated, high-performance technologies paired with service. We look forward to continuing to support the Katena customer base and expanding our surgical market presence via continued investment in organic growth and M&A.”
The Katena acquisition expands Corza’s portfolio of surgical products and adds significant scale, product breadth and infrastructure to Corza’s ophthalmic surgery segment, according to Corza Medical. This transaction represents Corza’s first add-on acquisition since its formation in January 2021 with the transformational merger of Surgical Specialties and TachoSil, a carve-out from Takeda Pharmaceutical.
“Katena is a brand with decades of trust and clinical relevance in ophthalmic surgery,” Corza CEO Dan Croteau said. “Corza is committed to providing service and value to customers, transforming surgical outcomes and changing the lives of patients around the globe. The acquisition of Katena further enables us to execute on our mission with products that allow customers to maintain, improve, and restore sight for their patients.”
Founded in 1975 and headquartered in Parsippany, N.J., Katena provides ophthalmic products used in cataract, glaucoma, and corneal surgeries. Katena’s product offering includes precision surgical instruments, single-use devices, and specialty biologics that have been sold in more than 110 countries to more than 5,000 customers, including hospitals, ambulatory surgery centers and distributors. Katena has more than 200 employees throughout North America and Europe.
William Blair acted as financial advisor and Latham & Watkins provided legal counsel to Corza.
Corza Medical is a global manufacturer of surgical technologies. With a global team of over 1,800 employees supporting clinicians, distributors and medical device companies worldwide, Corza provides healthcare professionals a platform of surgical technologies with brands including Quill barbed sutures, Sharpoint Plus and Look surgical sutures, Sharpoint ophthalmic knives, and the TachoSil fibrin sealant patch.
The company purchased Katena Products Inc. but did not disclose deal terms. "The addition of Katena is highly complementary to our existing surgical product portfolio," Corza Executive Chairman Greg Lucier said. "This acquisition underscores our dedication to serving customers with differentiated, high-performance technologies paired with service. We look forward to continuing to support the Katena customer base and expanding our surgical market presence via continued investment in organic growth and M&A.”
The Katena acquisition expands Corza’s portfolio of surgical products and adds significant scale, product breadth and infrastructure to Corza’s ophthalmic surgery segment, according to Corza Medical. This transaction represents Corza’s first add-on acquisition since its formation in January 2021 with the transformational merger of Surgical Specialties and TachoSil, a carve-out from Takeda Pharmaceutical.
“Katena is a brand with decades of trust and clinical relevance in ophthalmic surgery,” Corza CEO Dan Croteau said. “Corza is committed to providing service and value to customers, transforming surgical outcomes and changing the lives of patients around the globe. The acquisition of Katena further enables us to execute on our mission with products that allow customers to maintain, improve, and restore sight for their patients.”
Founded in 1975 and headquartered in Parsippany, N.J., Katena provides ophthalmic products used in cataract, glaucoma, and corneal surgeries. Katena’s product offering includes precision surgical instruments, single-use devices, and specialty biologics that have been sold in more than 110 countries to more than 5,000 customers, including hospitals, ambulatory surgery centers and distributors. Katena has more than 200 employees throughout North America and Europe.
William Blair acted as financial advisor and Latham & Watkins provided legal counsel to Corza.
Corza Medical is a global manufacturer of surgical technologies. With a global team of over 1,800 employees supporting clinicians, distributors and medical device companies worldwide, Corza provides healthcare professionals a platform of surgical technologies with brands including Quill barbed sutures, Sharpoint Plus and Look surgical sutures, Sharpoint ophthalmic knives, and the TachoSil fibrin sealant patch.